4. Ong HL, Kuo HC. Bladder dysfunction does not affect long-term success rate of the retropubic suburethral sling procedure in women with stress urinary incontinence. Low Urin Tract Symptoms 2019;11:O168-73. PMID:
30484955
6. Deng DY. Urinary incontinence in women. Med Clin North Am 2011;95:101-9. PMID:
21095414
8. Tran H, Rutman M. Female outlet obstruction after anti-incontinence surgery. Urology 2018;112:1-5. PMID:
28888751
9. Dumoulin C, Hay-Smith J. Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. Cochrane Database Syst Rev 20180;(1):CD005654.
10. Labrie J, Berghmans BL, Fischer K, Milani AL, van der Wijk I, Smalbraak DJ, et al. Surgery versus physiotherapy for stress urinary incontinence. N Engl J Med 2013;369:1124-33.
11. Ladi-Seyedian S, Kajbafzadeh AM, Sharifi-Rad L, Shadgan B, Fan E. Management of non-neuropathic underactive bladder in children with voiding dysfunction by animated biofeedback: a randomized clinical trial. Urology 2015;85:205-10. PMID:
25444633
12. Minardi D, d’Anzeo G, Parri G, Polito M Jr, Piergallina M, El Asmar Z, et al. The role of uroflowmetry biofeedback and biofeedback training of the pelvic floor muscles in the treatment of recurrent urinary tract infections in women with dysfunctional voiding: a randomized controlled prospective study. Urology 2010;75:1299-304.
13. Ford AA, Rogerson L, Cody JD, Ogah J. Mid-urethral sling operations for stress urinary incontinence in women. Cochrane Database Syst Rev 2015;(7):CD006375.
14. Kim SJ, Kim JC. Influence of preoperative detrusor underactivity on the continence rate and satisfaction after midurethral sling patient with stress urinary incontinence. Low Urin Tract Symptoms 2010;2:95-9.
16. Chen CJ, Yeoh SC, Yeh HT, Hsiao SM, Kuo HC. Surgical results in women with detrusor underactivity and stress urinary incontinence undergoing suburethral sling procedure-Predictive factors for successful outcome. Low Urin Tract Symptoms 2020;12:143-9. PMID:
31691485
22. Radadia KD, Farber NJ, Shinder B, Polotti CF, Milas LJ, Tunuguntla HSGR. Management of postradical prostatectomy urinary incontinence: a review. Urology 2018;113:13-9. PMID:
29031841
23. Gomha MA, Boone TB. Voiding patterns in patients with postprostatectomy incontinence: urodynamic and demographic analysis. J Urol 2003;169:1766-9. PMID:
12686829
24. Trigo Rocha F, Gomes CM, Mitre AI, Arap S, Srougi M. A prospective study evaluating the efficacy of the artificial sphincter AMS 800 for the treatment of postradical prostatectomy urinary incontinence and the correlation between preoperative urodynamic and surgical outcomes. Urology 2008;71:85-9. PMID:
18242371
26. Han JS, Brucker BM, Demirtas A, Fong E, Nitti VW. Treatment of post-prostatectomy incontinence with male slings in patients with impaired detrusor contractility on urodynamics and/or who perform Valsalva voiding. J Urol 2011;186:1370-5. PMID:
21855941
27. Yamanishi T, Yasuda K, Kamai T, Tsujii T, Sakakibara R, Uchiyama T, et al. Combination of a cholinergic drug and an alpha-blocker is more effective than monotherapy for the treatment of voiding difficulty in patients with underactive detrusor. Int J Urol 2004;11:88-96. PMID:
14706012
29. Sekido N, Kida J, Wakamatsu D, Okada H, Matsuya H. Effects of α1 antagonist and cholinesterase inhibitor on cystometric parameters in lumbar canal stenosis rats with underactive bladder. Urology 2014;84:1248 e9-15.
30. Barendrecht MM, Oelke M, Laguna MP, Michel MC. Is the use of parasympathomimetics for treating an underactive urinary bladder evidence-based? BJU Int 2007;99:749-52. PMID:
17233798
31. Gaitonde S, Malik RD, Christie AL, Zimmern PE. Bethanechol: is it still being prescribed for bladder dysfunction in women? Int J Clin Pract 2019;73:e13248. PMID:
30112787
33. Siddighi S, Karram MM. Surgical and nonsurgical approaches to treat voiding dysfunction following antiincontinence surgery. Curr Opin Obstet Gynecol 2007;19:490-5. PMID:
17885467
34. Bersch U, Göcking K, Pannek J. The artificial urinary sphincter in patients with spinal cord lesion: description of a modified technique and clinical results. Eur Urol 2009;55:687-93. PMID:
18394784
39. Goins WF, Yoshimura N, Phelan MW, Yokoyama T, Fraser MO, Ozawa H, et al. Herpes simplex virus mediated nerve growth factor expression in bladder and afferent neurons: potential treatment for diabetic bladder dysfunction. J Urol 2001;165:1748-54.
40. Isali I, Mahran A, Khalifa AO, Sheyn D, Neudecker M, Qureshi A, et al. Gene expression in stress urinary incontinence: a systematic review. Int Urogynecol J 2020;31:1-14.
41. Lee CL, Kuo HC. Efficacy and safety of mirabegron, a β3 -adrenoceptor agonist, in patients with detrusor hyperactivity and impaired contractility. Low Urin Tract Symptoms 2019;11:O93-7.
42. Wang CC, Lee CL, Kuo HC. Efficacy and safety of intravesical onabotulinumtoxinA injection in patients with detrusor hyperactivity and impaired contractility. Toxins (Basel) 2016;8:82.
43. Hennessey DB, Hoag N, Gani J. Sacral neuromodulation for detrusor hyperactivity with impaired contractility. Neurourol Urodyn 2017;36:2117-22.